Genetics Consortium

The CurePSP Genetics Consortium is a group neurologists, geneticists, and other scientists from the United States, United Kingdom, and Germany.

Working in collaboration with neuroscientists throughout the world, their goal is to search the entire human genome for genes related to PSP and CBD. This search will identify previously unsuspected abnormal biochemical pathways against which scientists may be able to target therapeutic interventions.

Principal Investigator and Coordinator
Gerard D. Schellenberg, PhD
University of Pennsylvania, School of Medicine
Philadelphia, Pennsylvania

Bernie Devlin, PhD
University of Pittsburgh, Graduate School of Public Health
Pittsburgh, Pennsylvania

Dennis Dickson, MD
Mayo Clinic, College of Medicine
Jacksonville, Florida

Matthew J. Farrer, PhD
Mayo Clinic, College of Medicine
Jacksonville, Florida

Hakon Hakonarson, PhD
Children's Hospital of Philadelphia, Center for Applied Genomics
Philadelphia, Pennsylvania

John Hardy, PhD
UCL Institute of Neurology
London, United Kingdom

Günter U. Höglinger, MD
Philipps University
Marburg, Germany

Andrew J. Lees, MD, FRCP
UCL Institute of Neurology
London, United Kingdom

Ulrich Müller, MD, PhD
Justus Liebig University, Institute for Human Genetics
Giessen, Germany

Rosa Rademakers, PhD
Mayo Clinic, College of Medicine
Jacksonville, Florida

Rohan de Silva, DPhil
UCL Institute of Neurology
London, United Kingdom

Chang-En Yu, PhD
University of Washington, School of Medicine
Seattle, Washington